{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:01:01Z","timestamp":1763535661825,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Staphylococcus epidermidis<\/jats:italic> infections are a common occurrence in hospitals, particularly in catheter-related bloodstream and surgical site infections and infective endocarditis. Higher daptomycin minimum inhibitory concentration (MIC) values may be associated with daptomycin treatment failure among patients with <jats:italic>S. epidermidis<\/jats:italic> infections. We therefore conducted a retrospective cohort study to determine the predictive value of daptomycin susceptibility. A retrospective study was undertaken in 1,337 patients with <jats:italic>S. epidermidis<\/jats:italic> infections. Data were collected from 1 January 2013 to 31 December 2016 at Ehime University Hospital, and included the following clinicopathological factors for evaluation: age, sex, resistance to vancomycin or teicoplanin, and history of antimicrobial therapy. Multiple analysis was performed using logistic regression to identify factors that independently and significantly affected the daptomycin resistance. Daptomycin-resistant <jats:italic>S. epidermidis<\/jats:italic> was identified in 38 (2.8%) patients. According to the multiple analysis, only higher MIC values (\u226516\u2009mg\/L) for teicoplanin (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) were independently associated with an increased risk of developing daptomycin resistance. In conclusion, higher teicoplanin MIC values may predict resistance to daptomycin treatment in <jats:italic>S. epidermidis<\/jats:italic> infections.<\/jats:p>","DOI":"10.1038\/s41598-019-55149-z","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T11:02:54Z","timestamp":1575630174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis"],"prefix":"10.1038","volume":"9","author":[{"given":"Shinichi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinobu","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-0162","authenticated-orcid":false,"given":"Koichiro","family":"Suemori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamichi","family":"Tauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"55149_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1517\/13543784.8.8.1223","volume":"8","author":"FP Tally","year":"1999","unstructured":"Tally, F. P. et al. Daptomycin: a novel agent for Gram-positive infections. Expert opinion on investigational drugs 8, 1223\u20131238, https:\/\/doi.org\/10.1517\/13543784.8.8.1223 (1999).","journal-title":"Expert opinion on investigational drugs"},{"key":"55149_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/ajhp\/62.11.1145","volume":"62","author":"CA Schriever","year":"2005","unstructured":"Schriever, C. A., Fernandez, C., Rodvold, K. A. & Danziger, L. H. Daptomycin: a novel cyclic lipopeptide antimicrobial. Am. J. Health Syst. Pharm. 62, 1145\u20131158 (2005).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"55149_CR3","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1086\/428616","volume":"40","author":"A Mangili","year":"2005","unstructured":"Mangili, A., Bica, I., Snydman, D. R. & Hamer, D. H. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40, 1058\u20131060, https:\/\/doi.org\/10.1086\/428616 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"55149_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijantimicag.2015.05.008","volume":"46","author":"S Stefani","year":"2015","unstructured":"Stefani, S. et al. Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence. Int. J. Antimicrob. Agents 46, 278\u2013289, https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.05.008 (2015).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"55149_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.vetmic.2008.09.009","volume":"134","author":"A Piette","year":"2009","unstructured":"Piette, A. & Verschraegen, G. Role of coagulase-negative staphylococci in human disease. Vet. Microbiol. 134, 45\u201354, https:\/\/doi.org\/10.1016\/j.vetmic.2008.09.009 (2009).","journal-title":"Vet. Microbiol."},{"key":"55149_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/07853890802337045","volume":"41","author":"I Uckay","year":"2009","unstructured":"Uckay, I. et al. Foreign body infections due to Staphylococcus epidermidis. Ann. Med. 41, 109\u2013119, https:\/\/doi.org\/10.1080\/07853890802337045 (2009).","journal-title":"Ann. Med."},{"key":"55149_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrmicro2182","volume":"7","author":"M Otto","year":"2009","unstructured":"Otto, M. Staphylococcus epidermidis\u2013the \u2018accidental\u2019 pathogen. Nature reviews. Microbiology 7, 555\u2013567, https:\/\/doi.org\/10.1038\/nrmicro2182 (2009).","journal-title":"Nature reviews. Microbiology"},{"key":"55149_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijantimicag.2010.10.018","volume":"37","author":"SH Lin","year":"2011","unstructured":"Lin, S. H., Lai, C. C., Tan, C. K., Liao, W. H. & Hsueh, P. R. Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Int. J. Antimicrob. Agents 37, 179\u2013181, https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.10.018 (2011).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"55149_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/aac.50.3.1079-1082.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui, L., Tominaga, E., Neoh, H. M. & Hiramatsu, K. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50, 1079\u20131082, https:\/\/doi.org\/10.1128\/aac.50.3.1079-1082.2006 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55149_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/aac.50.2.428-438.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui, L. et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50, 428\u2013438, https:\/\/doi.org\/10.1128\/aac.50.2.428-438.2006 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55149_CR11","doi-asserted-by":"publisher","first-page":"e0125818","DOI":"10.1371\/journal.pone.0125818","volume":"10","author":"C Garcia de la Maria","year":"2015","unstructured":"Garcia de la Maria, C. et al. Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration. PLoS One 10, e0125818, https:\/\/doi.org\/10.1371\/journal.pone.0125818 (2015).","journal-title":"PLoS One"},{"key":"55149_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1128\/jcm.01085-08","volume":"47","author":"S Ibrahem","year":"2009","unstructured":"Ibrahem, S. et al. Carriage of methicillin-resistant Staphylococci and their SCCmec types in a long-term-care facility. J. Clin. Microbiol. 47, 32\u201337, https:\/\/doi.org\/10.1128\/jcm.01085-08 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"55149_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/JCM.37.1.39-44.1999","volume":"37","author":"K Sieradzki","year":"1999","unstructured":"Sieradzki, K., Roberts, R. B., Serur, D., Hargrave, J. & Tomasz, A. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J. Clin. Microbiol. 37, 39\u201344 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"55149_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1128\/AAC.42.1.100","volume":"42","author":"K Sieradzki","year":"1998","unstructured":"Sieradzki, K., Villari, P. & Tomasz, A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42, 100\u2013107 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55149_CR15","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1128\/AAC.47.8.2682-2684.2003","volume":"47","author":"V Laganas","year":"2003","unstructured":"Laganas, V., Alder, J. & Silverman, J. A. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis. Antimicrob. Agents Chemother. 47, 2682\u20132684 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55149_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","volume":"41","author":"L Cui","year":"2003","unstructured":"Cui, L. et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41, 5\u201314 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"55149_CR17","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1128\/aac.01728-08","volume":"53","author":"PS Stewart","year":"2009","unstructured":"Stewart, P. S., Davison, W. M. & Steenbergen, J. N. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 53, 3505\u20133507, https:\/\/doi.org\/10.1128\/aac.01728-08 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55149_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano, A. et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46, 193\u2013200, https:\/\/doi.org\/10.1086\/524667 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"55149_CR19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00431-013-1978-7","volume":"172","author":"S Watanabe","year":"2013","unstructured":"Watanabe, S. et al. Treatment with linezolid in a neonate with meningitis caused by methicillin-resistant Staphylococcus epidermidis. Eur. J. Pediatr. 172, 1419\u20131421, https:\/\/doi.org\/10.1007\/s00431-013-1978-7 (2013).","journal-title":"Eur. J. Pediatr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55149-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55149-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55149-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:03:34Z","timestamp":1671296614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55149-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55149"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55149-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18533"}}